Reda SM, Cant AJ

Idioma: Español
Referencias bibliográficas: 7
Paginas: 55-57
Archivo PDF: 330.14 Kb.

FRAGMENTO

Las inmunodeficiencias primarias son un grupo heterogéneo de enfermedades genéticas raras que afectan el desarrollo o el funcionamiento de la inmunidad innata o la adaptativa. La mayoría de los pacientes que las padecen tienen mayor susceptibilidad a infecciones tanto comunes como raras, a veces con desenlace fatal.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Medical Advisory Committee of the Immune Deficiency Foundation, Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM, Bonilla FA, Conley ME, Cunningham- Rundles C, Filipovich AH, Fuleihan R, Gelfand EW, Hernandez- Trujillo V, Holland SM, Hong R, Lederman HM, Malech HL, Miles S, Notarangelo LD, Ochs HD, Orange JS, Puck JM, Routes JM, Stiehm ER, Sullivan K, Torgerson T, Winkelstein J. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 2014;133(4):961-6.

2. Papadopoulou-Alataki E, Hassan A, Davies EG. Prevention of infection in children and adolescents with primary immunodeficiency disorders. Asian Pac J Allergy Immunol 2012;30(4):249-58.

3. Principi N, Esposito S. Vaccine use in primary immunodeficiency disorders. Vaccine 2014;32(30):3725-31.

4. Martin J. Vaccine-derived poliovirus from long term excretor and the end game of polio eradication. Biologicals 2006;34:117-22.

5. Chapel H, Cunningham-Rundles C. Update in understanding common variable immuno-deficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145:709–27.

6. Kerr J, Quinti I, Eibl M, Chapel H, Späth PJ, Sewell WA, Salama A, van Schaik IN, Kuijpers TW, Peter HH. Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe. Front Immunol 2014;5:629.

7. World Health Organization (WHO) Lists (Adult and Pediatric) of Essential medicines. Disponible en: http://www. who.int/medicines/publications/essentialmedicines/en/